Characterizing the reproducibility in using a liver microphysiological system for assaying drug toxicity, metabolism, and accumulation-Reference-Cited by-同舟云学术

Characterizing the reproducibility in using a liver microphysiological system for assaying drug toxicity, metabolism, and accumulation

Published:2021-04-03 Issue:3 Volume:14 Page:1049-1061
ISSN:1752-8054
Container-title:Clinical and Translational Science
language:en
Short-container-title:Clin Transl Sci

Author:

Rubiano Andrés¹,Indapurkar Amruta¹,Yokosawa Ryosuke¹,Miedzik Alina²,Rosenzweig Barry¹,Arefin Ayesha¹,Moulin Chloe M.¹,Dame Keri¹,Hartman Neil¹,Volpe Donna A.¹,Matta Murali K.¹,Hughes David J.²,Strauss David G.¹³,Kostrzewski Tomasz²,Ribeiro Alexandre J. S.¹

Affiliation:

1. Center for Drug Evaluation and Research Office of Translational Sciences Office of Clinical Pharmacology Division of Applied Regulatory Science US Food and Drug Administration Silver Spring Maryland USA

2. CN Bio Innovations Limited Cambridge UK

3. Center for Drug Evaluation and Research Office of Translational Sciences Office of Clinical Pharmacology US Food and Drug Administration Silver Spring Maryland USA

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cts.12969

Reference50 articles.

1. Liver Microphysiological Systems for Predicting and Evaluating Drug Effects

2. Liver microphysiological systems development guidelines for safety risk assessment in the pharmaceutical industry

3. Microphysiological systems for ADME-related applications: current status and recommendations for system development and characterization

4. Liver ‘organ on a chip’

5. Emerging Role of Organ‐on‐a‐Chip Technologies in Quantitative Clinical Pharmacology Evaluation

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trends in organ-on-a-chip for pharmacological analysis;TrAC Trends in Analytical Chemistry;2024-11

2. Microfluidic human physiomimetic liver model as a screening platform for drug induced liver injury;Biomaterials;2024-10

3. A hollow fiber membrane-based liver organoid-on-a-chip model for examining drug metabolism and transport;2024-08-15

4. Multicellular, fluid flow-inclusive hepaticin vitromodels using NANOSTACKS^TM: a human-relevant model for drug response prediction;2024-08-14

5. Liver-on-chips for drug discovery and development;Materials Today Bio;2024-08